Herantis Pharma Oyj (HRTIS) — Cash Flow Quality Index
Herantis Pharma Oyj (HRTIS) has a Cash Flow Quality Index of -1.41x as of December 2023. Operating cash flow of €-2.92 Million is below net income of €2.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Herantis Pharma Oyj generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Herantis Pharma Oyj Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Herantis Pharma Oyj across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Herantis Pharma Oyj investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Herantis Pharma Oyj (2023–2023)
Year-by-year earnings quality comparison for Herantis Pharma Oyj. For live market cap and the full company financial profile, see HRTIS market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -16.57x | €-4.64 Million | €279.84K | — |